SCHEMBL5887204

SCHEMBL5887204

ClC1=C(c2cccc(Cl)c2)C(c2ccc3ccccc3c2)=C(Cl)C[CH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.41
CNR1 P21554 1/20 0.39
BACE1 P56817 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
ALOX5 P09917 1/20 0.35
CYP1A2 P05177 4/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
CYP2C19 P33261 1/20 0.34
SLC6A3 Q01959 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
MAP4K4 O95819 1/20 0.34
PLAU P00749 1/20 0.34
CYP1A1 P04798 3/20 0.33
CYP1B1 Q16678 3/20 0.33
GSTP1 P09211 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23025048 0.78 CYP2A6 (0.60) CYP2A6CNR1BACE1HSD17B1HSD17B2
SCHEMBL16672417 0.72 CYP2A6 (0.52) CYP2A6CNR1BACE1HSD17B1HSD17B2
SCHEMBL6340147 0.71 HSD17B1 (0.47) CYP2A6CNR1BACE1HSD17B1HSD17B2
SCHEMBL6407116 0.71 MAPT (0.35) CYP2A6BACE1SLC6A2SLC6A4MAP4K4
SCHEMBL25681064 0.70 CYP2A6 (0.50) CYP2A6CNR1BACE1HSD17B1HSD17B2
SCHEMBL19917084 0.69 BACE1 (0.51) CYP2A6CNR1BACE1HSD17B1HSD17B2
SCHEMBL20602130 0.69 TP53 (0.50) CYP2A6BACE1HSD17B1HSD17B2CYP1A2
SCHEMBL30340636 0.69 TP53 (0.50) CYP2A6BACE1HSD17B1HSD17B2CYP1A2
SCHEMBL24361492 0.68 TP53 (0.49) CYP2A6BACE1HSD17B1HSD17B2CYP1A2
SCHEMBL24153392 0.68 BACE1 (0.50) CYP2A6CNR1BACE1HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed
JP-2006501194-A 2006-01-12 JP claimed
EP-1525190-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-04-27 EP claimed
WO-2004007463-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-01-22 WO claimed